Net Cash Provided by (Used in) Operating Activities |
-1.2M |
USD |
-85.4% |
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
-232M |
USD |
-189% |
Dec 31, 2022 |
2022 |
Net Cash Provided by (Used in) Investing Activities |
233M |
USD |
|
Dec 31, 2022 |
2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.57M |
USD |
-75.1% |
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
713K |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Gross |
409K |
USD |
+97% |
Dec 31, 2022 |
Q4 2022 |
Deferred Income Tax Expense (Benefit) |
2.82M |
USD |
|
Dec 31, 2022 |
2022 |
Deferred Federal Income Tax Expense (Benefit) |
-212K |
USD |
-2.28% |
Dec 31, 2022 |
2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Current Federal Tax Expense (Benefit) |
2.8M |
USD |
|
Dec 31, 2022 |
2022 |
Deferred Tax Assets, Net of Valuation Allowance |
449K |
USD |
+116% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Sep 30, 2023 |
Q3 2023 |